Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hoepner

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
CNS Neuroscience & Therapeutics|June 14, 2018
Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of FingolimodMaria Eleftheria Evangelopoulos, Andrei Miclea, Lisa Schrewe, et al.
CNS Neuroscience & Therapeutics|October 11, 2023
Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysisMaud Bagnoud, Jana Remlinger, Sandrine Joly, et al.
Cureus|August 18, 2025
Neurological and Immunological Insights Into Post-COVID-19 Syndrome: A Single-Center Retrospective StudyLara Diem, Simona Daepp, Vincenzo P Introcaso, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|January 15, 2020
Visual Outcomes of Plasma Exchange Treatment of Steroid-Refractory Optic Neuritis: A Retrospective Monocentric AnalysisNic Skorupka, Andrei Miclea, Katarzyna Aleksandra Jalowiec, et al.
Frontiers in Cellular and Infection Microbiology|February 25, 2026
Synthetic peptide V11A reduces bacterial load and inflammation in pneumococcal meningitisJanine Lux, Maria Erhardt, Linus Rechsteiner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 21, 2014
Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimodRobert Hoepner, Joachim Havla, Christian Eienbröker, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 24, 2015
Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasisRobert Hoepner, Simon Faissner, Anja Klasing, et al.
Therapeutic Advances in Neurological Disorders|May 28, 2021
Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapiesChristoph Friedli, Lara Diem, Helly Hammer, et al.
Wiener Klinische Wochenschrift|June 15, 2026
Monitoring physical activity by fitness tracking devices : Usage, acceptance and willingness to share data in patients with multiple sclerosisHelly Hammer, Robert Hoepner, Marie Louise Aicher, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 10, 2023
Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System ManifestationsJana Remlinger, Maud Bagnoud, Ivo Meli, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
CNS Neuroscience & Therapeutics|June 14, 2018
Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of FingolimodMaria Eleftheria Evangelopoulos, Andrei Miclea, Lisa Schrewe, et al.
CNS Neuroscience & Therapeutics|October 11, 2023
Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysisMaud Bagnoud, Jana Remlinger, Sandrine Joly, et al.
Cureus|August 18, 2025
Neurological and Immunological Insights Into Post-COVID-19 Syndrome: A Single-Center Retrospective StudyLara Diem, Simona Daepp, Vincenzo P Introcaso, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|January 15, 2020
Visual Outcomes of Plasma Exchange Treatment of Steroid-Refractory Optic Neuritis: A Retrospective Monocentric AnalysisNic Skorupka, Andrei Miclea, Katarzyna Aleksandra Jalowiec, et al.
Frontiers in Cellular and Infection Microbiology|February 25, 2026
Synthetic peptide V11A reduces bacterial load and inflammation in pneumococcal meningitisJanine Lux, Maria Erhardt, Linus Rechsteiner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 21, 2014
Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimodRobert Hoepner, Joachim Havla, Christian Eienbröker, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 24, 2015
Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasisRobert Hoepner, Simon Faissner, Anja Klasing, et al.
Therapeutic Advances in Neurological Disorders|May 28, 2021
Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapiesChristoph Friedli, Lara Diem, Helly Hammer, et al.
Wiener Klinische Wochenschrift|June 15, 2026
Monitoring physical activity by fitness tracking devices : Usage, acceptance and willingness to share data in patients with multiple sclerosisHelly Hammer, Robert Hoepner, Marie Louise Aicher, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 10, 2023
Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System ManifestationsJana Remlinger, Maud Bagnoud, Ivo Meli, et al.
Pageof 13